Endometriosis is a condition in which tissue similar to the lining of the uterus grows outside the uterus, often causing pain and infertility. Currently, endometriosis can only be definitively diagnosed through invasive procedures like laparoscopy and biopsy.
The purpose of this study is to investigate whether the proteins Synuclein Gamma (SNCG) and B-Cell Lymphoma 6 (BCL6), measurable in blood and menstrual fluid, can serve as non-invasive biomarkers to diagnose or monitor endometriosis.
Inclusion Criteria for Endometriosis Group:
Exclusion Criteria for Endometriosis Group:
Inclusion Criteria for Control Group:
Exclusion Criteria for Endometriosis Group:
yasamans@triofertility.com4165060804
Patients who have been diagnosed with Endometriosis
Patients who have not been diagnosed with Endometriosis
Biomarkers in Endometriosis
Biomarkers in the Endometrial Fluid, Tissue, and Follicular Fluid of Moderate/Severe Endometriosis Patients
Blood and Tissue Markers for Improving Diagnosis and Prognosis of Endometriosis. (ENDOBIO)
Serum and Peritoneal Fluid Bank for Endometriosis Markers
Validation and Refinement of Noninvasive Diagnostic Biomarkers for Endometriosis, The ENDOmarker Protocol
EndoSearch : Endometriosis Biomarkers
ENDOMET - Novel Diagnostic Tools and Treatments for Endometriosis
EUmetriosis: Insights Into the Pathogenesis of Endometriosis